Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer

Fabiola N. Velazquez, Leiqing Zhang, Valentina Viscardi, Carolena Trocchia, Yusuf A. Hannun, Lina M. Obeid, Ashley J. Snider

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Breast cancer is a very heterogeneous disease, and ~30% of breast cancer patients succumb to metastasis, highlighting the need to understand the mechanisms of breast cancer progression in order to identify new molecular targets for treatment. Sphingosine kinase 1 (SK1) has been shown to be upregulated in patients with breast cancer, and several studies have suggested its involvement in breast cancer progression and/or metastasis, mostly based on cell studies. In this work we evaluated the role of SK1 in breast cancer development and metastasis using a transgenic breast cancer model, mouse mammary tumor virus-polyoma middle tumor-antigen (MMTV-PyMT), that closely resembles the characteristics and evolution of human breast cancer. The results show that SK1 deficiency does not alter tumor latency or growth, but significantly increases the number of metastatic lung nodules and the average metastasis size in the lung of MMTV-PyMT mice. Additionally, analysis of Kaplan-Meier plotter of human disease shows that high SK1 mRNA expression can be associated with a better prognosis for breast cancer patients. These results suggest a metastasis-suppressing function for SK1 in the MMTV-PyMT model of breast cancer, and that its role in regulating human breast cancer progression and metastasis may be dependent on the breast cancer type.

Original languageEnglish (US)
Article numbere0252311
JournalPloS one
Issue number5 May
StatePublished - May 2021
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer'. Together they form a unique fingerprint.

Cite this